{"version":"1.0","type":"link","title":"Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial.","author_name":"D'Haens G 외","author_url":"https://prs-insight.online/author/D%27Haens%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/155019","thumbnail_width":1200,"thumbnail_height":630}